KRMD

Analyst Sentiment

Wall St. Consensus
Buy
5 analysts·Limited coverage
70
Score
4 Buy (80%)1 Hold (20%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
480%
Hold
120%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$6.00
+55.3%
Consensus
$7.00
+81.1%
Bull
$8.00
+107.0%
12-Month Target Range5 analysts
$6.00$7.00$8.00
Current $3.86Consensus
Current Price
$3.86
Upside to Consensus
$3.14

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+16.94%
EPS
FY2028
Rev+13.11%
EPS+212.50%

Earnings Surprises

Recent Analyst Actions

Jan 13, 2026Craig-Hallum
Koru Medical price target raised to $7 from $6.25 at Craig-Hallum
Target:$7.00
+21.7%from $5.75
Dec 22, 2025Lake Street
Koru Medical price target raised to $8 from $6 at Lake Street
Target:$8.00
+32.7%from $6.03
Dec 17, 2025Canaccord Genuity
Koru Medical price target raised to $6 from $5 at Canaccord
Target:$6.00
+4.0%from $5.77
Nov 14, 2024Piper Sandler
Koru Medical Systems Inc. (KRMD) PT Raised to $3.50 at Piper Sandler
Target:$3.50
+13.1%from $3.10
Jul 2, 2024Canaccord Genuity
Canaccord Genuity Bullish on Koru Medical Systems Inc. (KRMD)
Target:$3.00
+33.3%from $2.25
Jan 6, 2023Piper Sandler
Piper Sandler Maintains Overweight on KORU Medical Systems, Raises Price Target to $4.5
Target:$4.50
+21.6%from $3.70
May 5, 2022Piper Sandler
Koru Medical investment spend to remain elevated, says Piper Sandler
Target:$3.00
+7.1%from $2.80